BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million

Reuters11-28

BRIEF-Marker <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Files For Mixed Shelf Of Up To $300 Million

Nov 27 (Reuters) - Marker Therapeutics Inc MRKR.O:

MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC FILING
MARKER THERAPEUTICS : SALES AGREEMENT PROSPECTUS COVERS OFFERING OF UP TO $11.4 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIME

Source text: [ID:n0001104659-24-123679]

Further company coverage: MRKR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486389701?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-28 07:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486389701","market":"us","top_or_hot":-1,"title":"BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Marker <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Files For Mixed Shelf Of Up To $300 Million </title></head><body><p><span>Nov 27 (Reuters)</span><span> - </span>Marker Therapeutics Inc <span>MRKR.O</span>:</p><ul><li><p>MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC FILING</p></li><li><p>MARKER THERAPEUTICS : SALES AGREEMENT PROSPECTUS COVERS OFFERING OF UP TO $11.4 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIME</p></li></ul><p>Source text: [ID:n0001104659-24-123679]</p><p>Further company coverage: <span>MRKR.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-28 07:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY1CI:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million Nov 27 (Reuters) - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC ...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY1CI:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRKR","symbol_name":"Marker Therapeutics, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241127:nFWN3MY1CI:1","article_id":"2486389701","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486389701","pubTimestamp":1732749698,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million Nov 27  - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC FILINGMARKER THERAPEUTICS : SALES AGREEMENT PROSPECTUS COVERS OFFERING OF UP TO $11.4 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIMESource text: [ID:n0001104659-24-123679]Further company coverage: MRKR.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRKR":"Marker Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"BRIEF-Marker Therapeutics申请高达3亿美元的混合货架","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRKR":0.9},"content_text":"BRIEF-Marker Therapeutics Files For Mixed Shelf Of Up To $300 Million Nov 27 (Reuters) - Marker Therapeutics Inc MRKR.O:MARKER THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC FILINGMARKER THERAPEUTICS : SALES AGREEMENT PROSPECTUS COVERS OFFERING OF UP TO $11.4 MILLION OF COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIMESource text: [ID:n0001104659-24-123679]Further company coverage: MRKR.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486389701"}